Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report
{{output}}
Background: Drug-induced liver injury poses a diagnostic challenge in oncology patients, especially those on immune checkpoint inhibitors, because symptoms often overlap with immune-mediated hepatitis. The increasing use of socia... ...
